
LUNGLIFE AI INC. DL-,0001
Share · USU5500L1045 · A3CY3X (XLON)
No Price
n/a
Company Profile for LUNGLIFE AI INC. DL-,0001 Share
LungLife AI, Inc., a cancer diagnostics company, develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology. It engages in developing LungLB, an AI enhanced, blood-based test to utilize machine learning to identify and count CTCs with reducing operator hands-on time and increasing test performance. The company was formerly known as Cynvenio Biosystems, Inc. and changed its name to LungLife AI, Inc. in May 2019. The company is based in Thousand Oaks, California.
Company Data
Name LUNGLIFE AI INC. DL-,0001
Company LungLife AI, Inc.
Website
https://www.lunglifeai.com
Primary Exchange
Frankfurt
Frankfurt
WKN A3CY3X
ISIN USU5500L1045
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Paul Pagano
Country United States of America
Currency EUR
Employees 0,0 T
Address 2545 West Hillcrest Drive, 91320 Thousand Oaks
IPO Date 2021-07-08
Ticker Symbols
| Name | Symbol |
|---|---|
| Frankfurt | 9H4.F |
| London | LLAI.L |
More Shares
Investors who hold LUNGLIFE AI INC. DL-,0001 also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.



